Daledalin (UK-3557-15) is an antidepressant which was synthesized and trialed for depression in the early 1970s, but was never marketed. It is a selective...
3 KB (174 words) - 18:23, 27 March 2024
Vestra) Viloxazine (Qelbree, Vivalan) Never marketed Amedalin (UK-3540-1) Daledalin (UK-3557-15) Edivoxetine (LY-2216684) Esreboxetine (AXS-14; PNU-165442G)...
7 KB (630 words) - 08:12, 26 September 2024
norepinephrine reuptake inhibitors: Amedalin Alseroxylon Ciclazindol Daledalin Edivoxetine Esreboxetine Lortalamine Mazindol Nisoxetine Reboxetine Talopram...
181 KB (19,541 words) - 07:13, 25 September 2024
norepinephrine reuptake inhibitors: Amedalin Alseroxylon Ciclazindol Daledalin Edivoxetine Esreboxetine Lortalamine Mazindol Nisoxetine Reboxetine Talopram...
117 KB (11,361 words) - 06:39, 30 September 2024
norepinephrine reuptake inhibitors: Amedalin Alseroxylon Ciclazindol Daledalin Edivoxetine Esreboxetine Lortalamine Mazindol Nisoxetine Reboxetine Talopram...
149 KB (13,773 words) - 18:42, 2 October 2024
norepinephrine reuptake inhibitors: Amedalin Alseroxylon Ciclazindol Daledalin Edivoxetine Esreboxetine Lortalamine Mazindol Nisoxetine Reboxetine Talopram...
21 KB (1,711 words) - 12:57, 29 September 2024
norepinephrine reuptake inhibitors: Amedalin Alseroxylon Ciclazindol Daledalin Edivoxetine Esreboxetine Lortalamine Mazindol Nisoxetine Reboxetine Talopram...
51 KB (4,638 words) - 00:56, 2 October 2024
norepinephrine reuptake inhibitors: Amedalin Alseroxylon Ciclazindol Daledalin Edivoxetine Esreboxetine Lortalamine Mazindol Nisoxetine Reboxetine Talopram...
136 KB (12,519 words) - 04:24, 22 September 2024
norepinephrine reuptake inhibitors: Amedalin Alseroxylon Ciclazindol Daledalin Edivoxetine Esreboxetine Lortalamine Mazindol Nisoxetine Reboxetine Talopram...
142 KB (15,105 words) - 07:45, 29 September 2024
norepinephrine reuptake inhibitors: Amedalin Alseroxylon Ciclazindol Daledalin Edivoxetine Esreboxetine Lortalamine Mazindol Nisoxetine Reboxetine Talopram...
93 KB (8,729 words) - 21:31, 30 September 2024